NCT04307134 2025-12-31
Besponsa Post Marketing Surveillance Study
Pfizer
Completed
Clinical Trials
4 trialsNCT07238907 2025-11-25
A Multi-center Retrospective Study of INO Treating B-ALL
Ruijin Hospital
Active not recruiting
NCT05597085 2025-02-04
A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment
Pfizer
Completed
NCT04456959 2022-09-28
InO
Pfizer
Completed